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PRELIMINARY AND SHORT REPORT
DELTA-AMINO LEVULINIC ACID DETERMINATIONS IN PATIENTS WITH
POLYMORPIIOIJS LIGHT ERUPTIONSt
EDWIN J. LEVY, M.D., MILTON M. CAHN, M.D., JOHN G. REINHOLD, Pn.D. AND BERTRAM SHAFFER, M.D.
Delta-amino-Levulinic acid is an intermediat
in the biosynthesis of porphyrins. This substance
is the immediate precursor of porphobilinogen,
which in turn gives rise to porphyrins (1). It is
assumed that condensation of glycine and
"active" succinate gives rise to L amino-B-
oxoadipate, which then loses one of its carboxyl
groups to yield delta-amino-levulinic acid (2).
Berlin, Neuberger and Scott (3) noted marked
photosensitivity in human subjects, who were fed
delta-amino-levulinic acid. One of us has observed
abnormal levels of this substance in the urine of
two patients with porphyria cutanea tarda.
The following study was done to determine the
amount of delta-amino-levulinic acid excreted in
the urine of patients with polymorphous light
eruption.
METHOD
Five patients with a history of polymorphous
light eruption, each summer for the past 6—20
years, were included in this study. Urinary delta-
amino-levulinic acid levels were determined on
these patients in February, 1057 when they were
free of eruption, in June, 1057 when their erup-
tions had flared following sun exposure, and again
after suppression of these eruptions with amodia-
quin (Camoquin) (4). The measurements of delta-
amino-levulinic acid were made by the method of
Shuster, using ethyl acetoacetate (5).'
Examination of the urine specimen under ultra-
violet light and the Watson-Schwartz test were
done for the detection of porphyrins and porpho-
bilinogen (6).
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RE5ULT5
There were no differences in the output of delta-
amino-levulinic acid in samples of urine of pa-
tients with polymorphous light eruption, prior to
eruption, during eruption, or after suppression
with amodiaquin (Camoquin), from that of
healthy controls. No porphyrins were detected by
ultraviolet light irradiation of urine specimens,
nor was porphobilinogen excretion increased as
shown by the Watson-Schwartz test in these
patients.
CONCLU5JON
There were no differences in the output of delta-
amino-levulinic acid in the urine of five patients
with polymorphous light eruption as compared to
that found in normal healthy persons.
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